Co-targeting mTORC and EGFR signaling as a therapeutic strategy in HNSCC

Head and neck squamous cell carcinomas (HNSCCs) are frequently altered along the PI3K/AKT/mTORC signaling axis. Despite excellent preclinical data, the use of compounds targeting this pathway as monotherapy has been underwhelming in initial clinical trials and identification of predictive biomarkers...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Swick, Adam D., Prabakaran, Prashanth J., Miller, Margot C., Javaid, Amal M., Fisher, Michael M., Sampene, Emmanuel, Ong, Irene M., Hu, Rong, Iida, Mari, Nickel, Kwangok P., Bruce, Justine Y., Wheeler, Deric L, Kimple, Randall J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505754/
https://ncbi.nlm.nih.gov/pubmed/28446642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados